Tandem Diabetes Care, Inc. (TNDM) has been on a downward spiral lately with significant selling pressure. After declining ...

As every investor would know, not every swing hits the sweet spot. But you want to avoid the really big losses like ...

Leerink Partnrs issued their FY2027 earnings per share estimates for shares of Tandem Diabetes Care in a research note issued ...

GAMMA Investing LLC increased its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 17.0% ...

Tandem Diabetes Care (NASDAQ: TNDM) had some encouraging news to report on the regulatory front Thursday, and after it hit the headlines investors piled into the stock. At the end of the day the ...

The prognosticator behind that piece of bad news was Citigroup's Joanne Wuensch, who issued one of her bank's 90-day catalyst watches on Tandem stock before the market open. Wuensch wrote in her ...

RBC sets a $65 price target for Tandem, citing strong growth prospects and margin improvements. RBC expects 51% gross margins in 2024, with the Mobi pump launch driving long-term profitability.

Analyst Jeff Johnson from Robert W. Baird reiterated a Hold rating on Tandem Diabetes Care (TNDM – Research Report) and increased the ...

IN AN INSIGHTFUL session presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2024, the ...

On Tuesday, Citi reiterated its Buy rating on Tandem Diabetes Care (NASDAQ:TNDM) stock with a steady price target of $57.00. The firm initiated a 90-day Negative Catalyst Watch on the company as ...

Despite that, it remains bullish on Tandem's prospects ... specialized medical device maker that a survey on its specialty, diabetes, indicated flat-line growth in the number of U.S. new patient ...